Efforts to Increase Representation in Prostate Cancer Clinical Trials at Lyndon B. Johnson Hospital

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT07591701
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
MALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Video — OTHER
    Participants will watch a short video in clinic. Participants will complete the two validated scales before and after viewing the video.

Study Details

The main rationale underlying this study is that prostate cancer clinical trials are lacking representation from racial and ethnic minority groups. Study proposal aims to target barriers at the participant, investigator, and health system level through specific interventions to increase the percentage of participants from these backgrounds on cancer clinical trials.

Key Dates

Start date
Jun 1, 2026
Status verified
May 2026
Primary completion
Jan 31, 2028
Completion
Jan 31, 2030

Study Design

Enrollment
60 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: Video Intervention to Prostate Cancer Patient
    The interventions will be conducted at Lyndon B. Johnson (LBJ) Hospital, a safety net facility that cares for a majority Latino and/or Black patient population.
  • Experimental: To Conduct Educational Sessions with Frontline Oncology Providers
    The investigator will conduct multiple one-hour educational sessions focused on participant-centered communication and cultural competency with the 42 oncology fellows during their academic half-days. Fellows attending the educational sessions will be invited to complete a Likert-style course evaluation form and provide open-ended feedback."

Primary Outcome Measure

Safety and Adverse Events (AEs) [ Time Frame: Through study completion; an average of 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
The University of Texas M. D. Anderson Cancer CenterHoustonTexas77090
Debanjan Pain, MD
[email protected]
713-745-0075
Debanjan Pain, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

By condition
Prostate cancer
By specialty
OncologyProstate oncologyMen's healthUrology
By research site
The University of Texas M. D. Anderson Cancer Center· Houston, TX

Related Studies